logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ANDRE JUICE (02218) cancelled 7.012 million shares on December 30th.

date
18:48 30/12/2025
avatar
GMT Eight
Andeli Juice (02218) announced the cancellation of 7,012,000 repurchased shares on December 30, 2025.
ANDRE JUICE (02218) announced the cancellation of 7.012 million repurchased shares on December 30, 2025.
Related Articles
HK Stock
HONG WEI ASIA (08191): The subscription price has been revised to HKD 0.128 per subscription share. Trading will resume on December 31st.
Companies such as Xintong Pharmaceuticals, Renben Corporation, and Wolei Intelligence have applied for IPO on the Shanghai Stock Exchange.
HK Stock
CAPITAL VC (02324) announced its annual performance, with a net profit of approximately HK$131 million, turning a loss into profit compared to the previous year.
HONG WEI ASIA (08191): The subscription price has been revised to HKD 0.128 per subscription share. Trading will resume on December 31st.
HK Stock
Companies such as Xintong Pharmaceuticals, Renben Corporation, and Wolei Intelligence have applied for IPO on the Shanghai Stock Exchange.
CAPITAL VC (02324) announced its annual performance, with a net profit of approximately HK$131 million, turning a loss into profit compared to the previous year.
HK Stock
RECOMMEND
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
icon
29/12/2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
icon
29/12/2025
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
icon
29/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.